www.fdanews.com/articles/61113-tanabe-seiyaku-launches-new-anti-rheumatic
TANABE SEIYAKU LAUNCHES NEW ANTI-RHEUMATIC
July 24, 2006
Tanabe Seiyaku launched Methotrexate tablets 2 mg TANABE (generic name: methotrexate), an anti-rheumatic drug for the indication of rheumatoid arthritis (RA) only if there is no indication of improvement when conventional treatment therapies such as nonsteroidal anti-inflammatory agents and other anti-rheumatic agents are used.
JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=12929)